Registered Malawi · PMRA

GRISEBEN 500 500MG TABLET

GRISEOFLUVIN

PMPB/PL253/76 TABLET

What it does

Griseofulvin is an antifungal medication used to treat fungal infections of the skin, hair, and nails.

Commonly used for: fungal infections of the skin, fungal infections of the hair, fungal infections of the nails (onychomycosis)

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
PMPB/PL253/76
Registration date
31/01/2014
Expiry date
31/03/2025
Status
Registered
Active ingredient
GRISEOFLUVIN
Dosage form
TABLET
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
-
Applicant / LTR
-
Country of origin
-

Source: Pharmacy and Medicines Regulatory Authority · fetched 2026-04-21 17:37:39 · updated 2026-09-29 04:33:04

Disclaimer: This information is sourced from Pharmacy and Medicines Regulatory Authority (Malawi). Always consult a qualified healthcare professional before using any medication.

About this medicine

Griseofulvin is an antifungal medication used to treat fungal infections of the skin, hair, and nails.

What it treats

  • fungal infections of the skin
  • fungal infections of the hair
  • fungal infections of the nails (onychomycosis)

How it works

It works by stopping the growth of fungus in the body.

Who it's for

Griseofulvin is for people with fungal infections that do not respond to topical treatments.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: griseofluvin

Griseofulvin is an antifungal medication primarily used to treat dermatophyte infections of the skin, hair, and nails. It is derived from the Penicillium griseofulvum fungus and works by inhibiting fungal cell mitosis and growth. Griseofulvin is typically administered orally and is known for its effectiveness against a variety of superficial fungal infections.

Indications

  • Tinea capitis
  • Tinea corporis
  • Tinea pedis
  • Tinea cruris
  • Onychomycosis (fungal nail infections)

Dosage

Children: Refer to specific prescribing guidelines or consult the BNF for Children for the appropriate paediatric dosage.

Adults: Refer to specific prescribing guidelines or consult the BNF for the appropriate adult dosage.

Mechanism of action

Griseofulvin binds to keratin in the skin, hair, and nails, preventing the growth of fungi by disrupting the mitotic spindle in fungal cells. This interferes with cell division, leading to the eventual death of the fungus. The binding of griseofulvin to keratin makes the tissues resistant to fungal infection.

Pharmacodynamics

Griseofulvin exhibits fungistatic properties, meaning it inhibits the growth of fungi rather than killing them outright. It is particularly effective against dermatophytes, including Trichophyton, Microsporum, and Epidermophyton species. The drug's effectiveness depends on its concentration at the site of infection and its ability to penetrate keratinous tissues.

Pharmacokinetics

Griseofulvin is absorbed from the gastrointestinal tract and its absorption is enhanced when taken with a fatty meal. The drug is distributed throughout the body, particularly accumulating in keratin-containing tissues. It has a half-life of approximately 24 hours, allowing for once or twice daily dosing. Griseofulvin undergoes hepatic metabolism and is excreted primarily in the urine. Its pharmacokinetics can be influenced by factors such as age, liver function, and concurrent medications.

Contra-indications

  • Porphyria
  • Severe liver disease
  • Hypersensitivity to griseofulvin or any excipients

Adverse effects

  • Headache
  • Nausea
  • Diarrhea
  • Dizziness
  • Fatigue
  • Rash
  • Photosensitivity
  • Hepatotoxicity

Interactions

  • Warfarin (may increase anticoagulant effect)
  • Oral contraceptives (may reduce effectiveness)
  • Barbiturates (may decrease griseofulvin levels)
  • Phenytoin (may decrease griseofulvin levels)
  • Cyclosporine (may decrease effectiveness of cyclosporine)

Precautions

  • Monitor liver function during treatment
  • Use with caution in patients with a history of alcohol abuse
  • Avoid sun exposure due to risk of photosensitivity
  • Use with caution in patients with renal impairment

Pregnancy

Griseofulvin is not recommended during pregnancy due to potential risks to the fetus, especially in the first trimester.

Breast-feeding

Griseofulvin is excreted in breast milk; caution should be exercised when administering to nursing mothers.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Formulations

  • Oral tablets
  • Oral suspension

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.